VTR vs WELL: Which Is the Better Buy in 2026?
Last updated August 2026
Short answer
WELL is the larger of the two ($168.93B market cap): the incumbent the market prices for continued execution (71.58x forward earnings, beta 0.76). VTR is the smaller challenger ($47.97B), actually pricier on forward earnings (114.50x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
VTR vs WELL: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | VTR | WELL | What it tells you |
|---|---|---|---|
| Market cap | $47.97B | $168.93B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 114.50 | 71.58 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 170.02 | 105.13 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.72 | 0.76 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 77% of range | 78% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 3.27 | 3.77 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: WELL is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how VTR and WELL affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. VTR and WELL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined VTR and WELL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Ventas (VTR) do?
Ventas, Inc. is an S&P 500 healthcare real estate investment trust that owns roughly 1,400 properties across North America and the United Kingdom, spanning senior housing communities, outpatient medical buildings, and research and lab (life science) assets. Its defining shift has been toward its senior housing operating portfolio (SHOP), which now accounts for more than half of net operating income and gives Ventas direct exposure to occupancy, rate, and margin trends rather than just fixed lease income. The company owns over 850 senior housing communities, and management has leaned hard into buying them, raising 2026 investment guidance to about $3 billion because acquiring communities has looked more attractive than building.
What does Welltower (WELL) do?
Welltower Inc. is the largest healthcare REIT in the world, owning a portfolio of senior housing, assisted living, post-acute and long-term care, and outpatient medical real estate across the United States, the United Kingdom, and Canada. It makes money in two main ways: through its Senior Housing Operating Portfolio (SHOP), where it shares directly in the net operating income that property operators generate from residents, and through rents on triple-net leased seniors housing and care facilities plus outpatient medical buildings. Because SHOP income flows through to Welltower rather than being fixed rent, rising occupancy and room rates translate quickly into higher earnings, which is why the operating portfolio has become the company's main growth engine.
VTR vs WELL: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- VTR drivers: Senior housing (SHOP) demographic tailwind; Capital deployment into acquisitions.
- WELL drivers: Aging-demographics senior-housing tailwind; Operating-portfolio NOI growth.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: As an operating (SHOP-heavy) REIT, Ventas carries more earnings variability than a pure net-lease landlord because occupancy, labor costs, and rate growth flow straight to NOI. For WELL, welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds.
VTR or WELL: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick VTR if you believe its drivers more; WELL if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the VTR and WELL guides.
VTR vs WELL: the full fundamentals
VTR. VTR trades around $96 with a market cap near $47 billion, making it the second-largest healthcare REIT behind Welltower. At roughly a mid-20s price-to-FFO multiple, the market is paying up for a fifth consecutive year of double-digit senior housing NOI growth. The dividend yield is modest for a REIT at about 2.1%, reflecting both the growth premium and a payout that management has been rebuilding since the pandemic.
WELL. Healthcare REITs are valued on funds from operations (FFO) rather than EPS, because standard net income is weighed down by large non-cash depreciation charges on real estate. For Welltower the most important operating metric is same-store NOI growth in the Senior Housing Operating Portfolio, since that captures how much extra income the company earns as occupancy and room rates rise. Welltower trades at a notably higher FFO multiple, and a lower dividend yield, than most healthcare REIT peers, reflecting the market's confidence in its senior-housing growth, its scale, and its balance sheet; that premium is part of the investment case and part of the risk.
Headline figures (approximate, July 2026): VTR shows revenue (ttm) ~$5.7B, q1 2026 revenue ~$1.66B, normalized ffo/share (q1 2026) ~$0.94, 2026 ffo/share guidance ~$3.82-$3.89; WELL shows normalized ffo per share (2025) $5.29 (+~22.5%), 2026 normalized ffo guidance $6.09 to $6.25, shop same-store noi growth (q4 2025) ~20.4% YoY, revenue (2025) ~$10.84 billion (+~36%).
The bottom line: VTR vs WELL
VTR and WELL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined VTR and WELL exposure against your real portfolio. It is not an investment adviser.
Wondering how VTR or WELL fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Ventas with AI
Connect the broker you already use and ask Walnut's AI how VTR fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between VTR and WELL?
+
Ventas, Inc. Welltower Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is VTR or WELL the better stock?
+
Neither is universally better. WELL is the larger incumbent; VTR is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, VTR or WELL?
+
On forward P/E (as of August 2026), VTR trades at 114.50x and WELL at 71.58x, so WELL is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both VTR and WELL?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of VTR vs WELL?
+
VTR: As an operating (SHOP-heavy) REIT, Ventas carries more earnings variability than a pure net-lease landlord because occupancy, labor costs, and rate growth flow straight to NOI. A premium FFO multiple (roughly mid-20s price-to-FFO) leaves little room for disappointment if senior housing growth decelerates or supply eventually catches up. Interest rates matter twice: higher rates raise the cost of the debt REITs rely on and can pressure REIT valuations broadly. Large ongoing acquisitions carry integration and pricing risk, and any renewed pressure on senior housing occupancy (from a health event or weaker demand) would hit results directly. Life science and outpatient medical demand can also soften with tenant budgets. WELL: Welltower's share price is sensitive to interest rates, since higher rates raise borrowing costs and make REIT dividend yields less competitive against bonds. The senior-housing operating model also carries labor cost and staffing pressures and depends on occupancy holding up, so a weaker demand environment or wage inflation could compress margins. The stock trades at a premium valuation relative to many healthcare REIT peers, which leaves limited room for disappointment and makes it vulnerable to multiple compression. The company is also deploying capital aggressively, so acquisition execution, integration, and the cost of financing that growth are real risks if returns on new investments fall short.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell VTR or WELL; figures are approximate and dated (as of August 2026). Verify current data before investing.